Ozempic Face Risk Calculator
Estimate your risk of facial volume loss from GLP-1 weight loss medications
Medical Disclaimer: This tool provides general educational estimates. Always consult your prescribing physician or healthcare provider before making medication changes or interpreting results from population-based models.
Frequently Asked Questions
"Ozempic face" describes the gaunt, hollowed facial appearance that can result from rapid weight loss on GLP-1 receptor agonist medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). It occurs because significant weight loss depletes the subcutaneous facial fat pads that give the face its youthful, full appearance. The term was popularized by New York dermatologist Dr. Paul Jarrod Frank.
Facial volume loss from weight loss is not necessarily permanent but is difficult to reverse naturally. Some facial fat may return if weight is regained, though skin laxity may persist. Dermal fillers (hyaluronic acid) can restore volume temporarily, typically lasting 12-18 months. Autologous fat transfer offers more durable results. The best approach is prevention through gradual weight loss.
No. The severity varies significantly. Key determinants include age (patients over 40 are more susceptible), rate of weight loss, total weight lost (>15% increases visibility), baseline facial fat, genetics, smoking status, and sun exposure history. Many patients who lose weight gradually at younger ages experience minimal visible facial changes.
Evidence-based prevention strategies include: losing weight gradually (under 0.5% body weight per week), maintaining high protein intake (1.2-1.6g/kg/day), using retinoid-based skincare, practicing facial exercises (a 2018 Northwestern study showed 30 min daily improved cheek fullness), rigorous SPF 30+ sun protection, and staying well-hydrated.
Risk increases notably after age 40. Collagen production declines approximately 1% per year after age 30, and skin elasticity decreases progressively. By age 50, the skin has significantly reduced ability to retract and conform to reduced facial volume after fat loss.
Sources
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. Link
- Alam M, Walter AJ, Geisler A, et al. Association of Facial Exercise With the Appearance of Aging. JAMA Dermatol. 2018;154(3):365-367. Link
- Ganceviciene R, Liakou AI, Theodoridis A, et al. Skin anti-aging strategies. Dermatoendocrinol. 2012;4(3):308-319. Link
- Varani J, Dame MK, Rittie L, et al. Decreased collagen production in chronologically aged skin. Am J Pathol. 2006;168(6):1861-1868. Link
- Morita A. Tobacco smoke causes premature skin aging. J Dermatol Sci. 2007;48(3):169-175. Link
Methodology
This calculator evaluates six evidence-based risk factors for facial volume loss during GLP-1-mediated weight loss, producing a composite score from 0 to 100. Age contributes up to 30 points, reflecting the approximately 1% annual decline in dermal collagen production after age 30 (Varani et al., 2006). Rate of weight loss contributes up to 30 points, based on STEP 1 trial data showing that rapid loss exceeding 1% body weight per week significantly increases facial hollowing (Wilding et al., 2021). BMI contributes up to 15 points, baseline facial fat up to 10 points, smoking status up to 8 points, and weight fluctuation history up to 7 points.
The weighting scheme is derived from clinical literature on facial aging and weight loss but has not been independently validated as a predictive instrument. Individual outcomes depend heavily on genetics, skin quality, sun exposure history, and other factors not captured by this model.
Ozempic face risk depends on six factors: age (up to 30 pts), weight loss speed (up to 30 pts), BMI (up to 15 pts), baseline facial fat (up to 10 pts), smoking (up to 8 pts), and weight fluctuation history (up to 7 pts). Total score 0-100 maps to Low (0-25), Moderate (26-50), High (51-75), Very High (76-100). Key prevention: lose weight gradually (<0.5% body weight/week), use retinoids, facial exercises, SPF 30+, and maintain 1.2-1.6g protein/kg/day.
What else do you want to know?
Ask Pulse anything.